These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma. Yoo HY; Sung MK; Lee SH; Kim S; Lee H; Park S; Kim SC; Lee B; Rho K; Lee JE; Cho KH; Kim W; Ju H; Kim J; Kim SJ; Kim WS; Lee S; Ko YH Nat Genet; 2014 Apr; 46(4):371-5. PubMed ID: 24584070 [TBL] [Abstract][Full Text] [Related]
23. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta. Du J; Jiang B; Coffey RJ; Barnard J Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945 [TBL] [Abstract][Full Text] [Related]
24. T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment. Casulo C; O'Connor O; Shustov A; Fanale M; Friedberg JW; Leonard JP; Kahl BS; Little RF; Pinter-Brown L; Advani R; Horwitz S J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 28040682 [TBL] [Abstract][Full Text] [Related]
25. Mutation and association analysis of the Fyn kinase gene with alcoholism and schizophrenia. Ishiguro H; Saito T; Shibuya H; Toru M; Arinami T Am J Med Genet; 2000 Dec; 96(6):716-20. PubMed ID: 11121167 [TBL] [Abstract][Full Text] [Related]
26. G2A is an oncogenic G protein-coupled receptor. Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580 [TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas. Go JH; Yang WI; Ree HJ Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050 [TBL] [Abstract][Full Text] [Related]
28. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation. Sahai E; Alberts AS; Treisman R EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732 [TBL] [Abstract][Full Text] [Related]
29. The association study of three FYN polymorphisms with prophylactic lithium response in bipolar patients. Szczepankiewicz A; Skibinska M; Suwalska A; Hauser J; Rybakowski JK Hum Psychopharmacol; 2009 Jun; 24(4):287-91. PubMed ID: 19330793 [TBL] [Abstract][Full Text] [Related]
30. Mutational analysis reveals a single binding interface between RhoA and its effector, PRK1. Hutchinson CL; Lowe PN; McLaughlin SH; Mott HR; Owen D Biochemistry; 2011 Apr; 50(14):2860-9. PubMed ID: 21351730 [TBL] [Abstract][Full Text] [Related]
31. Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis. Ramírez de Molina A; Gallego-Ortega D; Sarmentero J; Bañez-Coronel M; Martín-Cantalejo Y; Lacal JC Cancer Res; 2005 Jul; 65(13):5647-53. PubMed ID: 15994937 [TBL] [Abstract][Full Text] [Related]
32. The insert region of RhoA is essential for Rho kinase activation and cellular transformation. Zong H; Kaibuchi K; Quilliam LA Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812 [TBL] [Abstract][Full Text] [Related]
33. FYN kinase gene: another glutamatergic gene associated with bipolar disorder? Szczepankiewicz A; Rybakowski JK; Skibinska M; Dmitrzak-Weglarz M; Leszczynska-Rodziewicz A; Wilkosc M; Hauser J Neuropsychobiology; 2009; 59(3):178-83. PubMed ID: 19468241 [TBL] [Abstract][Full Text] [Related]
34. Preferential occurrence of RHOA mutation in gastric and colorectal cancers. Kim MS; Yoo NJ; Lee SH Pathology; 2015 Oct; 47(6):598-9. PubMed ID: 26352114 [No Abstract] [Full Text] [Related]